BPC-157 + TB-500 is a synthetic research peptide blend supplied for laboratory research and analytical applications
The choice of diluent depends on the intended laboratory application
Managing and Reducing Dizziness While on Tirzepatide Slow titration is the gold standard for dizziness prevention
Developing portal hypertension as well as established portal hypertension were both rapidly counteracted in BDL rats (i.e., BPC 157 per-orally, in drinking water, since the end of week 4) (Sever et al., 2019)
This tube was centrifuged for 3 min at 5,000 g at 20C, the supernatant was discarded, and 1 mL of RNase-free water was added and vortexed with the pellet
They describe how the blend has been documented in practice, not a prescribed regimen